--- # === IDENTITY === id: finance/valuation/startup-valuation-by-stage/2026 canonical_question: "How do startup valuations work at each funding stage, and what drives them?" aliases: - "startup valuation by round" - "seed Series A B C valuation ranges" - "pre-money valuation by funding stage" - "venture capital valuation benchmarks" entity_type: concept domain: finance > valuation > Startup Valuation by Stage region: global jurisdiction: global temporal_scope: 2025-2026 # === VERIFICATION === last_verified: 2026-02-28 confidence: 0.83 version: 1.0 first_published: 2026-02-28 # === TEMPORAL VALIDITY === temporal_validity: status: volatile last_breaking_change: "Q1 2025 PitchBook/NVCA data release" next_review: 2026-08-27 change_sensitivity: high # === CONSTRAINTS === constraints: - "These are US market medians — European and Asian markets typically see 20-40% lower valuations at equivalent stages" - "AI/ML startups trade at 50-100% premiums over general tech at every stage, making sector-blind medians misleading" - "Valuations are pre-money — post-money includes the new capital raised, which changes the numbers significantly" - "Stage definitions are not standardized — one firm's 'seed' may be another's 'pre-seed' making cross-dataset comparisons unreliable" - "Historical stage-based ranges may not apply to companies that raised at peak 2021 valuations and face down-round dynamics" # === SKIP CONDITIONS === skip_this_unit_if: - condition: "User has a SaaS company with established ARR and needs metric-based valuation" use_instead: "finance/valuation/saas-valuation-framework/2026" - condition: "User needs public-company valuation multiples, not private startup benchmarks" use_instead: "finance/valuation/ebitda-multiples-by-industry/2026" - condition: "User needs revenue-based multiples for a company with meaningful revenue" use_instead: "finance/valuation/revenue-multiples-by-industry/2026" # === AGENT HINTS === inputs_needed: - key: "startup_stage" question: "What is the user's startup stage or fundraising context?" type: choice options: - "Pre-seed or seed stage — setting initial valuation expectations" - "Series A — translating traction into valuation" - "Series B/C+ — scaling-stage valuation benchmarking" - "Comparing valuation expectations across stages for planning" # === DISTRIBUTION === canonical_source: "https://knowledgelib.io/finance/valuation/startup-valuation-by-stage/2026" suggested_citation: "Source: knowledgelib.io — AI Knowledge Library (verified 2026-02-28)" # === RELATED UNITS === related_kos: related_to: - id: "finance/valuation/saas-valuation-framework/2026" label: "SaaS Valuation Framework" - id: "finance/valuation/revenue-multiples-by-industry/2026" label: "Revenue Multiples by Industry" - id: "finance/valuation/ebitda-multiples-by-industry/2026" label: "EBITDA Multiples by Industry" often_confused_with: - id: "finance/valuation/revenue-multiples-by-industry/2026" label: "Revenue Multiples by Industry (public-company metric, not stage-based)" depends_on: [] solves: [] alternative_to: [] # === SOURCES === sources: - id: src1 title: "Series A valuations in 2026: what founders need to know" author: Zeni url: https://www.zeni.ai/blog/series-a-valuations type: industry_report published: 2026-01-10 reliability: high - id: src2 title: "Series B valuations in 2026: What founders need to know" author: Zeni url: https://www.zeni.ai/blog/series-b-valuations type: industry_report published: 2026-01-15 reliability: high - id: src3 title: "From Pre-Seed to Series E: How Investors Evaluate Startups at Each Round in 2026" author: Pitchwise url: https://www.pitchwise.se/blog/the-complete-guide-to-seed-and-series-funding-rounds-for-founders-in-2026 type: industry_report published: 2026-01-20 reliability: high - id: src4 title: "AI Startup Funding Trends 2026: Valuations, Growth & Key Insights" author: Qubit Capital url: https://qubit.capital/blog/ai-startup-fundraising-trends type: industry_report published: 2026-02-01 reliability: moderate_high --- # Startup Valuation by Funding Stage ## Definition Startup valuation by funding stage refers to the benchmark pre-money valuation ranges that venture-backed companies typically command at each round of institutional financing, from pre-seed through Series C and beyond. These ranges are set primarily by negotiation between founders and investors, informed by comparable transactions, sector dynamics, traction metrics, and market conditions rather than by traditional financial metrics like earnings or cash flow. [src3] As of 2025-2026, typical US pre-money valuations are: Pre-seed $1M-$5M, Seed $10M-$16M median, Series A $30M-$50M median, Series B $100M-$145M median, and Series C $200M-$500M+. [src1, src2, src3] ## Key Properties - **Valuation driver at early stages**: Team quality, market size, and product vision — quantitative metrics have limited weight pre-revenue [src3] - **Valuation driver at growth stages**: Revenue run rate, growth rate, unit economics, and net revenue retention — investors shift to metric-based valuation at Series A+ [src1] - **Typical equity dilution per round**: 15-25% at each stage, meaning founders retain roughly 50-60% after seed and 30-40% after Series A [src3] - **AI/ML premium (2025-2026)**: Seed-stage AI companies show median pre-money valuations of ~$18M (vs ~$12M general tech); Series A AI valuations regularly exceed $50M [src4] - **Geographic variation**: Silicon Valley and NYC valuations exceed medians by 20-50%; secondary US markets and Europe trail by 20-40% [src1] ## Constraints - These are US market medians — European startups at equivalent stages typically see 20-40% lower valuations due to smaller exit markets and less capital availability [src1] - AI/ML startups in 2025-2026 trade at 50-100% premiums over general tech benchmarks at every stage, making sector-blind medians misleading [src4] - Deep tech, biotech, and hardware startups follow different valuation curves: lower at early stages (capital intensity, longer time-to-revenue) but potentially higher at later stages if milestones are met [src3] - Down rounds became more common in 2023-2024 but have partially normalized; companies that raised at peak 2021 valuations may not fit current ranges [src2] - Stage definitions are not standardized across VC firms — one firm's "seed" at $5M pre-money may be another's "pre-seed," making cross-dataset comparisons unreliable [src3] ## Framework Selection Decision Tree ``` START — User needs to understand startup valuation ├── What stage is the company at? │ ├── Pre-revenue, pre-product │ │ └── Startup Valuation by Stage (this unit) — use team/market benchmarks │ ├── Has revenue but pre-profit │ │ ├── SaaS with established ARR? │ │ │ └── → SaaS Valuation Framework (ARR-based multiples) │ │ └── Non-SaaS with revenue? │ │ └── → Revenue Multiples by Industry │ ├── Profitable with positive EBITDA │ │ └── → EBITDA Multiples by Industry │ └── Late-stage or pre-IPO │ └── → Combination: Revenue Multiples + DCF + comparable IPOs ├── Is this an AI/ML startup? │ ├── YES → Apply 50-100% premium to stage-based benchmarks [src4] │ └── NO → Use standard stage-based ranges ├── Is this outside the US? │ ├── YES → Apply 20-40% geographic discount to US medians │ └── NO → Use US medians directly └── Is the founder comparing to 2021 benchmarks? └── YES → Advise that 2021 was an outlier; 2025-2026 represents a normalized market ``` ## Application Checklist ### Step 1: Identify the correct funding stage - **Inputs needed**: Current revenue, product status, previous funding, and intended raise amount - **Output**: Stage classification (pre-seed, seed, Series A, B, or C) - **Constraint**: Stage is defined by the company's maturity, not the round label — a "seed" company raising $10M at $40M pre-money is actually at Series A by market standards [src3] ### Step 2: Apply sector-specific adjustments - **Inputs needed**: Industry vertical, competitive landscape, and current investor sentiment for the sector - **Output**: Adjusted valuation range reflecting sector premiums or discounts - **Constraint**: AI/ML startups command 50-100% premiums; biotech and hardware command 20-30% discounts at early stages due to capital intensity [src4] ### Step 3: Factor in traction and team quality - **Inputs needed**: Revenue growth rate, customer metrics (NRR, churn), team background, and previous exits - **Output**: Position within the stage range (bottom quartile, median, or top quartile) - **Constraint**: At seed stage, team pedigree (repeat founder, ex-FAANG) can justify top-quartile valuations even without revenue; at Series A+, metrics must support the position [src1] ### Step 4: Validate with comparable transactions - **Inputs needed**: 3-5 recent comparable raises in the same sector and stage - **Output**: Validated valuation range based on actual transaction data - **Constraint**: Comparables must be recent (within 6-12 months) — the venture market shifts rapidly and 2-year-old comparables may be outdated [src2] ## Anti-Patterns ### Wrong: Using stage-based medians without sector adjustment Telling an AI startup founder their seed round should be at $12M pre-money because "that's the median," when AI seed valuations are running at $18M+ in 2025-2026. Sector premiums can exceed the entire interquartile range. [src4] ### Correct: Starting with sector-specific benchmarks Begin with sector-specific data (e.g., AI seed medians at $18M) rather than broad market medians, then adjust for team, traction, and geography. [src4] ### Wrong: Assuming linear valuation progression between stages Expecting a 3x step-up from seed to Series A regardless of traction. A seed-stage company that raised at $15M pre-money but has not hit Series A milestones (typically $1M+ ARR for SaaS) may face a flat or down round rather than a 3x markup. [src1] ### Correct: Tying valuation progression to milestone achievement Each stage has expected milestones — seed to Series A requires product-market fit signals (typically $1-2M ARR for SaaS, clinical data for biotech). Valuation step-ups are earned by milestone achievement, not by the passage of time. [src1] ### Wrong: Comparing US and European valuations directly Stating that a European startup at $8M seed pre-money is "undervalued" because US peers raise at $12M+. The difference reflects structural factors: smaller exit markets, less venture capital availability, and different investor return expectations. [src3] ### Correct: Benchmarking within the same geography Compare European startups to European comparables and US startups to US comparables. Only cross-reference when the startup has US expansion plans that justify US-like valuations. [src3] ## Common Misconceptions - **Misconception**: Pre-money valuation determines how much the company is actually worth. **Reality**: Pre-money valuation in venture capital is a negotiated term that reflects investor return expectations and market dynamics, not an objective assessment of intrinsic value. A $20M pre-money valuation means investors believe the company could return 10-30x, not that the company's assets are worth $20M today. [src3] - **Misconception**: Higher valuation is always better for founders. **Reality**: An inflated valuation creates a "valuation overhang" — the company must grow into the valuation before the next round, or face a down round that damages morale, triggers anti-dilution provisions, and signals weakness to the market. Raising at a reasonable valuation with strong investors often produces better long-term outcomes. [src2] - **Misconception**: All startups at the same stage should have similar valuations. **Reality**: Intra-stage dispersion is enormous. Seed valuations in 2025-2026 range from $3M to $25M+ depending on sector (AI vs consumer), geography (SF vs Midwest), team (first-time vs repeat founder), and traction. The median tells you very little about any individual company. [src1] ## Comparison with Similar Concepts | Concept | Key Difference | When to Use | |---|---|---| | Startup Valuation by Stage | Negotiation-based, milestone-driven benchmarks | Pre-revenue and early-revenue startup fundraising | | Revenue Multiples | Metric-based valuation on actual revenue | Companies with meaningful revenue ($1M+) | | EBITDA Multiples | Earnings-based valuation for profitable companies | Profitable, established businesses | | SaaS Valuation Framework | ARR-based with SaaS-specific metrics (NRR, CAC) | SaaS companies with $1M+ ARR | | DCF Analysis | Discounted cash flow projections | Late-stage companies with predictable cash flows | ## When This Matters Fetch this when a user asks how much their startup is worth, what valuation to expect at a given funding round, how much equity to give up, or how AI premiums affect startup valuations. Also relevant when comparing fundraising benchmarks across stages or geographies. ## Related Units - [SaaS Valuation Framework](/finance/valuation/saas-valuation-framework/2026) - [Revenue Multiples by Industry](/finance/valuation/revenue-multiples-by-industry/2026) - [EBITDA Multiples by Industry](/finance/valuation/ebitda-multiples-by-industry/2026)